MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Globus pallidus interna deep brain stimulation for Parkinson’s Disease: Impact on Restless Legs Syndrome

A. Mahes, A. Wiltshire, M. San Luciano, S. Wang, J. Zuzuarregui (San Francisco, USA)

Meeting: 2025 International Congress

Keywords: Deep brain stimulation (DBS), Parkinson’s, Sleep disorders. See also Restless legs syndrome: Treatment

Category: Parkinson's Disease: Non-Motor Symptoms (non-Cognitive/ non-Psychiatric)

Objective: This study evaluated one-year outcomes of Restless Legs Syndrome (RLS) in a cohort of patients with Parkinson’s disease (PD) who underwent deep brain stimulation (DBS) at globus pallidus interna (GPi).

Background: Parkinson’s disease is a neurodegenerative disorder characterized by motor and non-motor symptoms, including sleep disorders. Restless legs syndrome is a sleep disorder characterized by a strong, irresistible urge to move one’s legs, affecting approximately 20% of patients with Parkinson’s disease. DBS is used to treat motor fluctuations associated with PD, however, little is known about the effect of DBS on non-motor symptoms such as RLS.

Method:

Patients with Parkinson’s disease who underwent GPi DBS surgery were administered an International Restless Legs Syndrome Study Group (IRLSSG) survey at baseline and 12 months postoperatively to assess the presence and severity of RLS symptoms. The impact of levodopa equivalent daily dose on RLS scores was also assessed. All results were analyzed with a paired t-test.

Results:

Out of 12 patients, five were found to have RLS at baseline. Six patients without RLS at baseline did not develop symptoms at 12 months. There was no significant change in the one-year IRLS scores of the entire cohort after DBS (p=0.78). Of those with RLS at baseline, scores showed no significant change 12 months after DBS (p=0.79). Levodopa equivalent daily dose did not significantly change from baseline to one year for the entire cohort (p=0.62) or the RLS-only group (p=0.59).

Conclusion: This study suggests that there is no significant effect on restless legs syndrome in patients who received GPi DBS. However, five patients experienced fluctuations in IRLS scores between baseline and 12 months, suggesting that the interaction between DBS and medications may have an influence on the results. A larger cohort study is needed to evaluate the interactions between DBS, medications, and non-motor symptoms of Parkinson’s disease.

Table 1

Table 1

Table 2

Table 2

To cite this abstract in AMA style:

A. Mahes, A. Wiltshire, M. San Luciano, S. Wang, J. Zuzuarregui. Globus pallidus interna deep brain stimulation for Parkinson’s Disease: Impact on Restless Legs Syndrome [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/globus-pallidus-interna-deep-brain-stimulation-for-parkinsons-disease-impact-on-restless-legs-syndrome-2/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/globus-pallidus-interna-deep-brain-stimulation-for-parkinsons-disease-impact-on-restless-legs-syndrome-2/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley